EGFR and lung adenocarcinoma: To validate the existence of TLSs in early-stage EGFR-mutant lung adenocarcinoma, we performed immunohistochemical (IHC) staining on continuous formalin-fixed and paraffin-embedded (FFPE) tumor surgical sections.